In situ cervical carcinoma incidence statistics

Cases

New cases of cervical cancer each year, 2017-2019 average, UK.

 

Age

Peak rate of cervical cancer in situ cases, 2017-2019, UK

 

Trend over time

Change in cervical carcinoma in situ incidence rates since the early 1990s, Females, UK

 

Cervical carcinoma in situ incidence rates (European age-standardised (AS) rate Open a glossary item) for females are significantly higher than the UK average in Wales and Northern Ireland and significantly lower than the UK average in England. Rates in Scotland are similar to the UK average. [1-4]

Cervical Carcinoma in situ (D06), Average Number of New Cases Per Year, Crude and European Age-Standardised (AS) Incidence Rates per 100,000 Female Population, UK, 2017-2019

  England Scotland Wales Northern Ireland UK
Female Cases 20,665 2,104 1,408 924 25,100
Crude Rate 73.0 75.4 88.4 96.7 74.6
AS Rate 71.6 74.7 94.1 96.0 73.5
AS Rate - 95% LCL 71.1 72.9 91.3 92.4 73.0
AS Rate - 95% UCL 72.2 76.5 97.0 99.6 74.0
Persons Cases 20,665 2,104 1,408 924 25,100
Crude Rate 36.9 38.7 44.8 49.1 37.8
AS Rate 35.7 37.9 47.0 48.6 36.7
AS Rate - 95% LCL 35.4 36.9 45.6 46.8 36.5
AS Rate - 95% UCL 36.0 38.8 48.4 50.4 37.0
95% LCL and 95% UCL are the 95% lower and upper confidence limits around the AS Rate Open a glossary item

References

  1. England data were provided by the National Cancer Registration and Analysis Service (NCRAS), part of the National Disease Registration Service (NDRS) in NHS England, on request through the Office for Data Release, January 2023. Similar data can be found here: https://www.cancerdata.nhs.uk/ 

  2.  Northern Ireland data were provided by the Northern Ireland Cancer Registry (NICR) on request, October 2021. Similar data can be found here:http://www.qub.ac.uk/research-centres/nicr/. 

  3. Welsh data were published by the Welsh Cancer Intelligence and Surveillance Unit (WCISU), Health Intelligence Division, Public Health Wales https://phw.nhs.wales/services-and-teams/welsh-cancer-intelligence-and-surveillance-unit-wcisu/cancer-reporting-tool-official-statistics/ June 2022. 

  4. Scotland data were provided by the Scottish Cancer Registry, Public Health Scotland (PHS) on request, May 2021. Similar data can be found here: https://publichealthscotland.scot/publications/show-all-releases?id=20468

About this data

Data is for UK, 2017-2019, ICD-10 D06.

Last reviewed:

In the UK in 2017-2019, on average each year less than 1% of new cases (0%) were in females aged 75 and over.[1-4] The highest incidence rates overall being in younger females - the converse pattern to most cancers.

Age-specific incidence rates rise steeply from around age 15-19 and peak in the 25-29 age group, then drop sharply. The highest rates are in the 25 to 29 age group.

Cervical Carcinoma In Situ (D06), Average Number of New Cases per Year and Age-Specific Incidence Rates per 100,000 Female Population, UK, 2017-2019

For cervical carcinoma in situ, most cases are identified through the cervical screening programme. Incidence increases rapidly when routine screening starts at age 25, then falls until routine screening ends at age 64, with very low rates thereafter. This reflects the diagnosis of prevalent cases at first-time screening, and the likely peak of HPV exposure in early adulthood.

See also

Cerivcal cancer mortality statistics by age

Cervical cancer surival statistics

Cervical cancer incidence statistics by age for all cancers

References

  1. England data were provided by the National Cancer Registration and Analysis Service (NCRAS), part of the National Disease Registration Service (NDRS) in NHS England, on request through the Office for Data Release, January 2023. Similar data can be found here: https://www.cancerdata.nhs.uk/ 

  2.  Northern Ireland data were provided by the Northern Ireland Cancer Registry (NICR) on request, October 2021. Similar data can be found here:http://www.qub.ac.uk/research-centres/nicr/. 

  3. Welsh data were published by the Welsh Cancer Intelligence and Surveillance Unit (WCISU), Health Intelligence Division, Public Health Wales https://phw.nhs.wales/services-and-teams/welsh-cancer-intelligence-and-surveillance-unit-wcisu/cancer-reporting-tool-official-statistics/ June 2022. 

  4. Scotland data were provided by the Scottish Cancer Registry, Public Health Scotland (PHS) on request, May 2021. Similar data can be found here: https://publichealthscotland.scot/publications/show-all-releases?id=20468

About this data

Data is for UK, 2017-2019, ICD-10 D06.

Last reviewed:

Cervical carcinoma in situ European age-standardised (AS) Open a glossary item incidence rates for females increased by 3% in the UK between 1993-1995 and 2017-2019.[1-4]

Over the last decade in the UK (between 2007-2009 and 2017-2019), cervical carcinoma in situ AS incidence rates for females decreased by 21%.

Cervical Carcinoma In Situ (ICD-10 D06), European Age-Standardised Incidence Rates, Female Population, 1993 to 2019

Cervical carcinoma in situ incidence rates have varied between age groups in females in the UK since the early 1990s.[1-4] Rates in 0-19s have decreased by 99%, in 20-24s have decreased by 64%, in 25-34s have increased by 38% (though the increase was only in the period before women who received routine human papillomavirus (HPV) vaccine reached this age group), in 35-49s have remained stable, in 50-64s have decreased by 24%, in 65-79s have decreased by 67% and in 80+s have remained stable.

Cervical Carcinoma In Situ (ICD-10 D06), European Age-Standardised Incidence Rates per 100,000 Female Population, By Age, UK, 1993-2019

Cervical carcinoma in situ incidence trends probably reflect the effective implementation of the UK cervical screening programmes in the late 1980s – most cases are identified through the screening programme. [5] Changing prevalence of risk factors probably also plays a part, particularly among younger women in more recent years. [5]

References

  1. England data were provided by the National Cancer Registration and Analysis Service (NCRAS), part of the National Disease Registration Service (NDRS) in NHS England, on request through the Office for Data Release, January 2023. Similar data can be found here: https://www.cancerdata.nhs.uk/ 

  2.  Northern Ireland data were provided by the Northern Ireland Cancer Registry (NICR) on request, October 2021. Similar data can be found here:http://www.qub.ac.uk/research-centres/nicr/. 

  3. Welsh data were published by the Welsh Cancer Intelligence and Surveillance Unit (WCISU), Health Intelligence Division, Public Health Wales https://phw.nhs.wales/services-and-teams/welsh-cancer-intelligence-and-surveillance-unit-wcisu/cancer-reporting-tool-official-statistics/ June 2022. 

  4. Scotland data were provided by the Scottish Cancer Registry, Public Health Scotland (PHS) on request, May 2021. Similar data can be found here: https://publichealthscotland.scot/publications/show-all-releases?id=20468

  5. Pesola F and Sasieni P. Impact of screening on cervical cancer incidence in England: a time trend analysis. BMJ 2019; 9(1) e026292. https://www.ncbi.nlm.nih.gov/pubmed/30679300

About this data

Data is for UK, 1993-2019, ICD-10 D06.

Last reviewed:

Cervical carcinoma in situ incidence rates (European age-standardised (AS) rates Open a glossary item) in England in females are 18% higher in the most deprived quintile compared with the least (2013-2017).[1]

It is estimated that there are around 2,000 more cases of cervical carcinoma in situ each year in England than there would be if every deprivation quintile had the same age-specific crude incidence rates as the least deprived quintile.

Cervical Carcinoma In Situ (D06), Estimated Average Number of Excess Cases per Year and European Age-Standardised Incidence Rates per 100,000 Population, by Deprivation Quintile, England, 2013-2017

See also

Data table: Cancer incidence rates and excess cases by cancer type in England

Incidence by deprivation for all cancer types combined

Cervical carcinoma in situ mortality by deprivation  (not directly comparable with incidence by deprivation)

Cancer incidence by deprivation for Scotland

Cancer incidence by deprivation for Wales

Cancer incidence by deprivation for Northern Ireland

References

  1. Calculated by the Cancer Intelligence Team at Cancer Research UK, April 2020. Based on method reported in National Cancer Intelligence Network Cancer by Deprivation in England Incidence, 1996-2010 Mortality, 1997-2011 . Using cancer incidence data 2013-2017 (Public Health England) and population data 2013-2017 (Office for National Statistics) by Indices of Multiple Deprivation 2015 income domain quintile, cancer type, sex, and five-year age band.

About this data

Data is for England, 2013-2017, ICD-10 D06

Last reviewed:

Cancer stats explained

See information and explanations on terminology used for statistics and reporting of cancer, and the methods used to calculate some of our statistics.

Cancer stats explained

Citation

You are welcome to reuse this Cancer Research UK content for your own work.
Credit us as authors by referencing Cancer Research UK as the primary source. Suggested styles are:

Web content: Cancer Research UK, full URL of the page, Accessed [month] [year].
Publications: Cancer Research UK ([year of publication]), Name of publication, Cancer Research UK.
Graphics (when reused unaltered): Credit: Cancer Research UK.
Graphics (when recreated with differences): Based on a graphic created by Cancer Research UK.

When Cancer Research UK material is used for commercial reasons, we encourage a donation to our life-saving research.
Send a cheque payable to Cancer Research UK to: Cancer Research UK, 2 Redman Place, London, E20 1JQ or

Donate online

Acknowledgements

We are grateful to the many organisations across the UK which collect, analyse, and share the data which we use, and to the patients and public who consent for their data to be used. Find out more about the sources which are essential for our statistics.